• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国纽约市大流行性流感疫苗的分发及接种剂量报告

Distribution of pandemic influenza vaccine and reporting of doses administered, New York, New York, USA.

作者信息

Marcello Roopa Kalyanaraman, Papadouka Vikki, Misener Mark, Wake Edward, Mandell Rebecca, Zucker Jane R

出版信息

Emerg Infect Dis. 2014 Apr;20(4):525-31. doi: 10.3201/eid2004.131114.

DOI:10.3201/eid2004.131114
PMID:24656328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3966398/
Abstract

In 2009, the New York City Department of Health and Mental Hygiene delivered influenza A(H1N1)pdm09 (pH1N1) vaccine to health care providers, who were required to report all administered doses to the Citywide Immunization Registry. Using data from this registry and a provider survey, we estimated the number of all pH1N1 vaccine doses administered. Of 2.8 million doses distributed during October 1, 2009-March 4, 2010, a total of 988,298 doses were administered and reported; another 172,289 doses were administered but not reported, for a total of 1,160,587 doses administered during this period. Reported doses represented an estimated 80%-85% of actual doses administered. Reporting by a wide range of provider types was feasible during a pandemic. Pediatric-care providers had the highest reporting rate (93%). Other private-care providers who routinely did not report vaccinations indicated that they had few, if any, problems, thereby suggesting that mandatory reporting of all vaccines would be feasible.

摘要

2009年,纽约市卫生和精神卫生部门向医疗服务提供者发放了甲型H1N1流感大流行病毒(pH1N1)疫苗,这些提供者被要求向全市免疫登记处报告所有接种剂量。利用该登记处的数据和一项提供者调查,我们估算了所有pH1N1疫苗接种剂量的数量。在2009年10月1日至2010年3月4日期间分发的280万剂疫苗中,共有988,298剂被接种并报告;另有172,289剂被接种但未报告,在此期间总共接种了1,160,587剂。报告的剂量估计占实际接种剂量的80% - 85%。在大流行期间,各类提供者进行报告是可行的。儿科护理提供者的报告率最高(93%)。其他通常不报告疫苗接种情况的私人护理提供者表示,他们几乎没有遇到问题,这表明强制报告所有疫苗接种情况是可行的。

相似文献

1
Distribution of pandemic influenza vaccine and reporting of doses administered, New York, New York, USA.美国纽约市大流行性流感疫苗的分发及接种剂量报告
Emerg Infect Dis. 2014 Apr;20(4):525-31. doi: 10.3201/eid2004.131114.
2
Evaluating the most effective distribution strategies to assure administration of pandemic H1N1 influenza vaccine to New York State children and adolescents: evaluation using the New York State Immunization Information System.评估确保纽约州儿童和青少年接种大流行性 H1N1 流感疫苗的最有效分发策略:利用纽约州免疫信息系统进行评估。
J Public Health Manag Pract. 2013 Nov-Dec;19(6):589-97. doi: 10.1097/PHH.0b013e31828002af.
3
2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa--successes and challenges.2009 年甲型 H1N1 流感病毒在非洲的疫苗接种——成功与挑战。
J Infect Dis. 2012 Dec 15;206 Suppl 1:S22-8. doi: 10.1093/infdis/jis535.
4
High effectiveness of pandemic influenza A (H1N1) vaccination in healthcare workers from a Portuguese hospital.甲型 H1N1 流感大流行疫苗在葡萄牙一家医院医护人员中的高有效性。
Int Arch Occup Environ Health. 2012 Oct;85(7):747-52. doi: 10.1007/s00420-011-0714-8. Epub 2011 Nov 2.
5
Reaching children never previously vaccinated for influenza through a school-located vaccination program.通过学校定位接种计划为从未接种过流感疫苗的儿童接种疫苗。
Am J Public Health. 2014 Jan;104(1):e45-9. doi: 10.2105/AJPH.2013.301671. Epub 2013 Nov 14.
6
Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.在芬兰医护人员中,先后接种大流行流感疫苗和季节性流感疫苗后对甲型 H1N1pdm09 流感病毒的抗体反应。
Influenza Other Respir Viruses. 2013 May;7(3):431-8. doi: 10.1111/j.1750-2659.2012.00415.x. Epub 2012 Aug 23.
7
An immunization information system to meet evolving needs during the 2009-2010 Influenza A (H1N1) vaccination campaign.满足 2009-2010 年甲型 H1N1 流感疫苗接种运动期间不断变化的需求的免疫信息系统。
Disaster Med Public Health Prep. 2012 Dec;6(4):402-7. doi: 10.1001/dmp.2012.64.
8
Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.肯尼亚 2010 年医护人员接种单价流感 A(H1N1)2009 疫苗的效果和接种率。
Vaccine. 2013 Sep 23;31(41):4662-7. doi: 10.1016/j.vaccine.2013.07.005. Epub 2013 Jul 13.
9
Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.2009 年甲型 H1N1 流感疫苗 1 剂接种对预防 7 月龄-9 岁儿童因大流行 H1N1 流感住院的效果。
J Infect Dis. 2012 Jul 1;206(1):49-55. doi: 10.1093/infdis/jis306. Epub 2012 May 2.
10
Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients.甲型H1N1流感大流行后医护人员持续低水平流感疫苗接种情况:意大利针对高危患者的医护环境中的横断面研究
BMC Infect Dis. 2015 Aug 12;15:329. doi: 10.1186/s12879-015-1090-x.

引用本文的文献

1
COVID-19 vaccine distribution planning using a congested queuing system-A real case from Australia.使用拥堵排队系统进行COVID-19疫苗分配规划——来自澳大利亚的一个真实案例。
Transp Res E Logist Transp Rev. 2022 Jul;163:102749. doi: 10.1016/j.tre.2022.102749. Epub 2022 May 30.
2
A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain.一种通过在新冠疫苗供应链中针对疫苗可及性不确定性切割超平面构建的数据驱动鲁棒优化模型。
Omega. 2022 Jul;110:102637. doi: 10.1016/j.omega.2022.102637. Epub 2022 Mar 11.
3
Incorporating research and evaluation into pandemic influenza vaccination preparedness and response.将研究与评估纳入大流行性流感疫苗接种的准备和应对工作中。
Emerg Infect Dis. 2014 Apr;20(4):713-714. doi: 10.3201/eid2004.140224.

本文引用的文献

1
Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.2009 年甲型 H1N1 流感疫苗 1 剂接种对预防 7 月龄-9 岁儿童因大流行 H1N1 流感住院的效果。
J Infect Dis. 2012 Jul 1;206(1):49-55. doi: 10.1093/infdis/jis306. Epub 2012 May 2.
2
Description of a large urban school-located 2009 pandemic H1N1 vaccination campaign, New York City 2009-2010.描述 2009-2010 年纽约市大型城市学校定位 2009 年大流行性 H1N1 疫苗接种运动。
J Urban Health. 2012 Apr;89(2):317-28. doi: 10.1007/s11524-011-9640-z.
3
Protecting the Public from H1N1 through Points of Dispensing (PODs).通过分发点(PODs)保护公众免受甲型H1N1流感侵害。
Biosecur Bioterror. 2011 Mar;9(1):13-21. doi: 10.1089/bsp.2010.0049. Epub 2011 Mar 1.
4
Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009.基于新型 H1N1 流感导致的类流感疾病人群估计的病死率:纽约市,2009 年 5 月-6 月。
PLoS One. 2010 Jul 21;5(7):e11677. doi: 10.1371/journal.pone.0011677.
5
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.2009年甲型H1N1流感大流行病毒感染的临床特征
N Engl J Med. 2010 May 6;362(18):1708-19. doi: 10.1056/NEJMra1000449.
6
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.2009年甲型H1N1流感单价疫苗的使用:免疫实践咨询委员会(ACIP)的建议,2009年
MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8.
7
Emergence of a novel swine-origin influenza A (H1N1) virus in humans.一种新型猪源甲型流感病毒(H1N1)在人类中的出现。
N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7.